Samuel L. Collins

1.5k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Samuel L. Collins is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Physiology. According to data from OpenAlex, Samuel L. Collins has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 10 papers in Immunology and 8 papers in Physiology. Recurrent topics in Samuel L. Collins's work include Tracheal and airway disorders (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Voice and Speech Disorders (6 papers). Samuel L. Collins is often cited by papers focused on Tracheal and airway disorders (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Voice and Speech Disorders (6 papers). Samuel L. Collins collaborates with scholars based in United States, Canada and United Kingdom. Samuel L. Collins's co-authors include Maureen R. Horton, Jonathan D. Powell, Kevin Shenderov, Yee Chan‐Li, Charles G. Drake, Michael A. Lutz, Jeanne Kowalski, Ching-Tai Huang, Ronald H. Schwartz and Amanda L. Blackford and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Nature Immunology.

In The Last Decade

Samuel L. Collins

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune dysregulation as a driver of idiopathic pulmonary fibrosis

2021 191 citations Kevin Shenderov, Samuel L. Collins et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Samuel L. Collins

Since Specialization

Citations

This map shows the geographic impact of Samuel L. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel L. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel L. Collins more than expected).

Fields of papers citing papers by Samuel L. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel L. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel L. Collins. The network helps show where Samuel L. Collins may publish in the future.

Co-authorship network of co-authors of Samuel L. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel L. Collins. A scholar is included among the top collaborators of Samuel L. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel L. Collins. Samuel L. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Localized Knockout of E‐Cadherin in Subglottic Mucosa Increases Fibrosis 2025 ·Otolaryngology ·(unknown), Samuel L. Collins, Yee Chan‐Li, Ioan Lina, Alexander Gelbard, Kevin Motz, Alexander T. Hillel	0
2	Similarity Network Analysis of the Adaptive Immune Response in the Proximal Airway 2024 ·The Laryngoscope ·Evan Clark, (unknown), (unknown), Ruth J. Davis, Samuel L. Collins, Alexander T. Hillel, Marisol Ramirez‐Solano, Quanhu Sheng, Celestine N. Wanjalla, S. Mallal, Alexander Gelbard	1
3	Serum S100A8/A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis 2024 ·The Laryngoscope ·(unknown), (unknown), (unknown), Samuel L. Collins, Yee Chan‐Li, (unknown), Ioan Lina, Alexander Gelbard, Alexander T. Hillel, Kevin Motz	0
4	Characterizing the T Cell Repertoire in the Proximal Airway in Health and Disease 2023 ·The Laryngoscope ·Evan Clark, (unknown), (unknown), Ruth J. Davis, Samuel L. Collins, Alexander T. Hillel, Marisol Ramirez‐Solano, Quanhu Sheng, Celestine N. Wanjalla, S. Mallal, Alexander Gelbard	3
5	Mapping Genetic Susceptibility to Stenosis in the Proximal Airway 2023 ·The Laryngoscope ·(unknown), William S. Tierney, Ruth J. Davis, Elizabeth Wohler, Nara Sobreira, Alexander T. Hillel, Samuel L. Collins, Marisol Ramirez‐Solano, Quanhu Sheng, Alexander Gelbard	5
6	Sirolimus-eluting airway stent reduces profibrotic Th17 cells and inhibits laryngotracheal stenosis 2023 ·JCI Insight ·Kevin Motz, Ioan Lina, Idris Samad, Michael K. Murphy, Madhavi Duvvuri, Ruth J. Davis, Alexander Gelbard, Liam Chung, Yee Chan‐Li, Samuel L. Collins, Jonathan D. Powell, Jennifer H. Elisseeff, Maureen R. Horton, Alexander T. Hillel	16
7	Localizing Hormone Receptor Expression to Cellular Compartments in Idiopathic Subglottic Stenosis 2023 ·The Laryngoscope ·(unknown), Evan Clark, (unknown), Ruth J. Davis, Alexander T. Hillel, Samuel L. Collins, Marisol Ramirez‐Solano, Quanhu Sheng, Alexander Gelbard	6
8	Dysfunctional Epithelial Barrier Is Characterized by Reduced E‐Cadherin in Idiopathic Subglottic Stenosis 2023 ·The Laryngoscope ·(unknown), (unknown), (unknown), Samuel L. Collins, (unknown), (unknown), Venkataramana K. Sidhaye, Ioan Lina, Alexander T. Hillel	6
9	Myeloid Phenotypes in Tracheostomy‐Associated Granulation Tissue 2023 ·The Laryngoscope ·(unknown), (unknown), Ioan Lina, Samuel L. Collins, Yee Chan‐Li, Alexander Gelbard, Alexander T. Hillel, Kevin Motz	7
10	Phenotypic Epithelial Changes in Laryngotracheal Stenosis 2022 ·The Laryngoscope ·Ioan Lina, Hsiu‐Wen Tsai, (unknown), (unknown), Ruth J. Davis, Kevin Motz, Samuel L. Collins, (unknown), Venkataramana K. Sidhaye, Alexander Gelbard, Alexander T. Hillel	18
11	Macrophage monocarboxylate transporter 1 promotes peripheral nerve regeneration after injury in mice 2021 ·Journal of Clinical Investigation ·Mithilesh Kumar Jha, (unknown), Atul Rawat, (unknown), Fang Yang, Svetlana Vidensky, Samuel L. Collins, Maureen R. Horton, Ahmet Höke, Guy A. Rutter, Alban Latrémolière, Jeffrey D. Rothstein, Brett M. Morrison	64
12	Immune dysregulation as a driver of idiopathic pulmonary fibrosis breakdown → 2021 ·Journal of Clinical Investigation ·Kevin Shenderov, Samuel L. Collins, Jonathan D. Powell, Maureen R. Horton	191
13	Inhibition of glutamine metabolism accelerates resolution of acute lung injury 2019 ·Physiological Reports ·(unknown), (unknown), Samuel L. Collins, Yee Chan‐Li, Jonathan D. Powell, Claire M. Doerschuk, Maureen R. Horton	16
14	Vaccinia vaccine–based immunotherapy arrests and reverses established pulmonary fibrosis 2016 ·JCI Insight ·Samuel L. Collins, Yee Chan‐Li, Min Hee Oh, (unknown), Nathachit Limjunyawong, Wayne Mitzner, Jonathan D. Powell, Maureen R. Horton	20
15	Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis 2014 ·International Journal of Biomedical Science ·Mark J. Hamblin, Michael Eberlein, Katharine E. Black, Robert W. Hallowell, Samuel L. Collins, Yee Chan‐Li, Maureen R. Horton	8
16	Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway 2013 ·Journal of Inflammation ·Katharine E. Black, Samuel L. Collins, Robert S. Hagan, Mark J. Hamblin, Yee Chan‐Li, Robert W. Hallowell, Jonathan D. Powell, Maureen R. Horton	49
17	Pulmonary Vaccination as a Novel Treatment for Lung Fibrosis 2012 ·PLoS ONE ·Samuel L. Collins, Yee Chan‐Li, Robert W. Hallowell, Jonathan D. Powell, Maureen R. Horton	21
18	Hyaluronan Fragments Promote Inflammation by Down-Regulating the Anti-inflammatory A2a Receptor 2011 ·American Journal of Respiratory Cell and Molecular Biology ·Samuel L. Collins, Katharine E. Black, Yee Chan‐Li, Young‐Hoon Ahn, Philip A. Cole, Jonathan D. Powell, Maureen R. Horton	49
19	Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression 2008 ·Journal of Inflammation ·Michael Eberlein, Kara Scheibner, Katharine E. Black, Samuel L. Collins, Yee Chan‐Li, Jonathan D. Powell, Maureen R. Horton	44
20	Egr-2 and Egr-3 are negative regulators of T cell activation 2005 ·Nature Immunology ·M. Safford, Samuel L. Collins, Michael A. Lutz, Amy N. Allen, Ching-Tai Huang, Jeanne Kowalski, Amanda L. Blackford, Maureen R. Horton, Charles G. Drake, Ronald H. Schwartz, Jonathan D. Powell	334

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact